CC-0
CC-0

Hormones are linked with sleep apnea, snoring in postmenopausal women

Embargoed until: Publicly released:
Peer-reviewed: This work was reviewed and scrutinised by relevant independent experts.

Observational study: A study in which the subject is observed to see if there is a relationship between two or more things (eg: the consumption of diet drinks and obesity). Observational studies cannot prove that one thing causes another, only that they are linked.

Case study: A study involving observations of a single patient or group of patients.

Survey: A study based solely on people’s responses to a series of questions.

People: This is a study based on research using people.

Middle-aged women with low levels of oestrogen and progesterone are more likely to snore and to report symptoms of obstructive sleep apnea, according to international and Australian scientists. The researchers analysed data from 774 women aged 40 to 67 from seven European countries between 2010 and 2012. The women completed questionnaires on their health and gave blood samples for hormone analysis. The team found a doubling of oestrone - a form of oestrogen - in the blood was linked to a 19% decrease in the chances of snoring, and a doubling of progesterone levels was linked with 9% decreased odds of snoring. Among snorers, a doubling of the concentrations of three estrogens was associated with a 17% to 23% decrease in odds of women breathing irregularly during sleep, while a doubling of progesterone was linked with 12% decreased odds of having woken with a choking sensation in the previous year. While further studies are required to confirm the findings, the authors say adjusting female sex hormones might decrease the high prevalence of obstructive sleep apnea and the risk of death.

Journal/conference: PLOS ONE

Link to research (DOI): 10.1371/journal.pone.0269569

Organisation/s: The University of Melbourne, University of Bergen, Norway

Funder: The work was funded by a postdoctoral scholarship from the University of Bergen.

Media release

From: PLOS

Hormones are linked with sleep apnea, snoring in postmenopausal women

Study found an association between obstructive sleep apnea risk and low estrogen and progesterone levels in women

Middle-aged women with low levels of estrogen and progesterone are more likely to snore and to report symptoms of obstructive sleep apnea, according to a new study published this week in the open-access journal PLOS ONE by Kai Triebner of University of Bergen, Norway, and colleagues.

The prevalence of obstructive sleep apnea—in which breathing stops and starts during sleep—is known to be higher in women after menopause. However no population-based study has previously examined whether this is the result of altered sex hormone levels. 

In the new study, the researchers analyzed data from 774 women aged 40 to 67 in the European Community Respiratory Health Survey, conducted in seven countries between 2010 and 2012. Women in the study participated in questionnaires on their respiratory health, women’s health factors, lifestyle and sleep, and gave blood samples for hormone analysis.

551 of the women in the study (71.2%) had been told they snored, and 411 of those women also reported other symptoms of sleep apnea. Among all women, a doubling of serum concentrations of estrone was associated with 19% decreased odds of snoring. A doubling of progesterone levels was associated with 9% decreased odds of snoring. Among snorers, a doubling of the concentrations of three estrogens (17β-estradiol, estrone and estrone 3-sulfate) was associated with 17% to 23% decreased odds of women having been told they breathe irregularly during sleep. A doubling of progesterone concentration, among snorers, was associated with 12% decreased odds of having woken with a choking sensation in the previous year.

The authors conclude that adjusting female sex hormones might be a strategy to decrease the high prevalence and associated morbidity of obstructive sleep apnea, but say that further longitudinal studies are required to confirm the findings.

The authors add: “Female sex hormones are crucial for health and disease, and especially after menopause the hormone status should be considered to develop holistic treatment strategies.” 

Attachments:

Note: Not all attachments are visible to the general public

  •  Research
    PLOS
    Web page
    The URL will go live after the embargo ends

News for:

Australia
International
VIC

Media contact details for this story are only visible to registered journalists.